Somerset Steps Up Once Again
With the 1st generic launch & CGT exclusivity for Calcium Gluconate 100mg/mL 50mL Vial
Also available in 100mL Vial
The company is the first to launch generic Calcium Gluconate 100mg/mL in 50mL vials. This product approval also received the FDA's Competitive Generic Therapy (CGT) designation with 180-day exclusivity.
Calcium Gluconate is an essential medicine used in the treatment of acute symptomatic hypocalcemia in pediatric and adult patients.
"We take our role as a partner to healthcare professionals very seriously, and one of the ways in which we can contribute to their efforts is by constantly enhancing and evolving our product portfolio to cater to patient needs," said Dr.
About Somerset Pharma, LLC
Somerset Pharma, LLC is a US-based pharmaceutical company specializing in sterile generic and specialized injectables, as well as ophthalmic products. Since its inception in 2013,
Backed by robust research and innovation capabilities and driven by a team of experienced professionals, the company is actively building a diversified portfolio of generic and specialty pharmaceuticals across various delivery systems.
For media inquiries or further information, please email: [email protected] or visit www.somersetpharma.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/somerset-steps-up-once-again-301970305.html
SOURCE Somerset Pharma LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- YESLY Launches Sparkling Protein Water Nationwide with Sprouts, Offering a Refreshing, Clean Alternative to Traditional Protein Shakes
- ATRenew to Report Third Quarter 2026 Financial Results on November 19, 2026
- Dizal to Present Latest Clinical Data at ASH 2026
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share